Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Careplus Group BhdXKLS:0163 +7.69% EV-to-EBITDA is -1.45 as of Aug. 06, 2026. The stock has 5 warning signs investors should review. Among 512 Medical Devices & Instruments companies, Careplus Group Bhd ranks worse than 195312.3% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Careplus Group Bhd's enterprise value is RM86.39 Mil.
Careplus Group Bhd's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was RM-59.49 Mil. Therefore, Careplus Group Bhd's EV-to-EBITDA for today is -1.45.
The historical rank and industry rank for Careplus Group Bhd's EV-to-EBITDA or its related term are showing as below:
XKLS:0163'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -37.86 Med: 2.49 Max: 53.41
Current: -1.45
During the past 13 years, the highest EV-to-EBITDA of Careplus Group Bhd was 53.41. The lowest was -37.86. And the median was 2.49.
XKLS:0163's EV-to-EBITDA is ranked worse than 100% of 512
companies
in the Medical Devices & Instruments industry
Industry Median: 14.51
vs XKLS:0163: -1.45
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Careplus Group Bhd (XKLS:0163) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Careplus Group Bhd's PE Ratio (TTM) for today is calculated as:
Careplus Group Bhd's share price for today is RM0.07.
Careplus Group Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-0.086.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Careplus Group Bhd's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0163 vs ISRG, BDX, MDLN: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Careplus Group Bhd's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Careplus Group Bhd EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Careplus Group Bhd's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Careplus Group Bhd's EV-to-EBITDA falls into.
Careplus Group Bhd's current Enterprise Value is RM86.39 Mil.
Careplus Group Bhd's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-59.49 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Careplus Group Bhd (XKLS:0163) has a EV-to-EBITDA of -1.45 as of Aug. 06, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Careplus Group Bhd. According to the industry distribution chart, Careplus Group Bhd ranks #999999 out of 512 companies in the Medical Devices & Instruments industry.
Is Careplus Group Bhd's EV-to-EBITDA too high?
Careplus Group Bhd's current EV-to-EBITDA is -1.45. Based on the distribution chart, Careplus Group Bhd ranks #999999 out of 512 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Careplus Group Bhd's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Careplus Group Bhd ranks #999999 out of 512 companies for EV-to-EBITDA. This places Careplus Group Bhd in the lower half of its industry. The industry median EV-to-EBITDA is 14.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.51, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Careplus Group Bhd. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Careplus Group Bhd's current EV-to-EBITDA is -1.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careplus Group Bhd stock overvalued right now?
Based on GuruFocus' analysis, Careplus Group Bhd (XKLS:0163) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.09, compared to a current price of RM0.07 — trading 22.2% below its estimated fair value. The current EV-to-EBITDA is -1.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Careplus Group Bhd (XKLS:0163), the current EV-to-EBITDA is -1.45 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Careplus Group Bhd is involved in the manufacturing, processing, and trading of gloves. The company's product consists of Latex exam gloves, Latex surgical gloves, and Nitrile exam gloves. Its Latex exam gloves are used in medical examinations and procedures, diagnostic procedures by the dentist, laboratory practices, and food handling practices. The Nitrile exam gloves are generally used in laboratory practices and the automotive industry. Geographically, it derives maximum revenue from Malaysia and the rest from North America, South America, Other Asia Pacific regions, and other regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0163 has been successfully added to your 
